Question

a client with symptoms of mild persistent asthma is now initiating treatment. which of the following is the preferred therapy that the nurse will teach the client to use at home?
oral sustained - release albuterol
subcutaneous omalizumab
inhaled beclomethasone
oral prednisone

Explanation:

For mild persistent asthma, the preferred long - term control therapy (to be used at home for maintenance) is an inhaled corticosteroid. Inhaled beclomethasone is an inhaled corticosteroid. Oral sustained - release albuterol is a bronchodilator, more for quick relief or as an add - on. Subcutaneous omalizumab is for severe asthma with specific IgE - mediated triggers. Oral prednisone is a systemic corticosteroid, used for acute exacerbations or more severe cases, not as first - line home maintenance for mild persistent asthma.

Answer:

C. Inhaled beclomethasone